BenjaminCCreelanMD

PubMed

• A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analyses.
  Boyle, T. A., Quinn, G. P., Schabath, M. B., Muñoz-Antonia, T., Saller, J. J., Duarte, L. F., Hair, L. S., Teer, J. K., Chiang, D. Y., Leary, R., Wong, C. C., Savchenk...> ;Cancer medicine. 2019 Nov 21
• Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
  Creelan, B. C., Ahmad, M. U., Kaszuba, F. J., Khalil, F. K., Welsh, A. W., Ozdemirli, M., Grant, N. N., Subramaniam, D. S.> ;The oncologist. 2019 Mar 8
• The NKG2A immune checkpoint - a new direction in cancer immunotherapy.
  Creelan, B. C., Antonia, S. J.> ;Nature reviews. Clinical oncology. 2019 Mar 3
• Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.
  Goldberg, M. E., Montesion, M., Young, L., Suh, J., Greenbowe, J., Kennedy, M., Giaccone, G., Akerley, W. L., Dowlati, A., Creelan, B. C., Hicks, J. K., Hesketh, P. J....> ;PloS one. 2018 Nov 28
• Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung Cancer.
  Schrock, A. B., Welsh, A., Chung, J. H., Pavlick, D., Bernicker, E. H., Creelan, B. C., Forcier, B., Ross, J. S., Stephens, P. J., Ali, S. M., Dagogo-Jack, I., Shaw, A...> ;Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Oct 28
• Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.
  Schrock, A. B., Zhu, V. W., Hsieh, W., Madison, R., Creelan, B., Silberberg, J., Costin, D., Bharne, A., Bonta, I., Bosemani, T., Nikolinakos, P., Ross, J. S., Miller,...> ;Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Jun 9
• 5 citations
  Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.
  Hellmann, M. D., Nathanson, T., Rizvi, H., Creelan, B. C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J. B., Mangarin, L. M., Abu-Akeel, M., Liu, C., Sauter, J. L., R...> ;Cancer cell. 2018 Apr 17
• Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program.
  Quinn, G. P., Pentz, R. D., Muñoz-Antonia, T., Boyle, T. A., Schabath, M. B., Pratt, C. L., Shaffer, A., Duarte, L. F., Bowman-Curci, M., Antonia, S. J., Chiappori, A....> ;Patient education and counseling. 2017 Dec 3
• 1 citation
  MET-GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors.
  Smith, M. A., Licata, T., Lakhani, A., Garcia, M. V., Schildhaus, H., Vuaroqueaux, V., Halmos, B., Borczuk, A. C., Chen, Y. A., Creelan, B. C., Boyle, T. A., Haura, E. B.> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Sep 1
• 118 citations
  First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
  Carbone, D. P., Reck, M., Paz-Ares, L., Creelan, B. C., Horn, L., Steins, M., Felip, E., van den Heuvel, M. M., Ciuleanu, T., Badin, F., Ready, N., Hiltermann, T. J., ...> ;The New England journal of medicine. 2017 Jun 22
• The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer.
  Tanvetyanon, T., Creelan, B. C., Antonia, S. J.> ;Expert review of anticancer therapy. 2016 Aug 5
• 1 citation
  Propelling Immunotherapy Combinations Into the Clinic.
  Tchekmedyian, N., Gray, J. E., Creelan, B. C., Chiappori, A. A., Beg, A. A., Soliman, H., Perez, B. A., Antonia, S. J.> ;Oncology (Williston Park, N.Y.). 2015 Dec 19
• 3 citations
  Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.
  Tanvetyanon, T., Creelan, B. C., Chiappori, A. A.> ;Cancer control : journal of the Moffitt Cancer Center. 2013 Dec 21
• 38 citations
  Update on immune checkpoint inhibitors in lung cancer.
  Creelan, B. C.> ;Cancer control : journal of the Moffitt Cancer Center. 2013 Dec 21
• A fatal case of alemtuzumab-associated interstitial pneumonitis.
  Creelan, B., Ferber, A.> ;Am J Ther.
• Join now to see all

Lectures

• Landscape of kinase rearrangements (kRE) detected in circulating tumor DNA (ctDNA). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018